EMEA-000366-PIP02-09-M05

Key facts

Invented name
Humira
Active substance
adalimumab
Therapeutic area
Gastroentology-Hepatology
Decision number
P/0342/2017
PIP number
EMEA-000366-PIP02-09-M05
Pharmaceutical form(s)
Solution for injection
Condition(s) / indication(s)
Treatment of ulcerative colitis
Route(s) of administration
Subcutaneous use
Contact for public enquiries
AbbVie Limited
Tel. +44 (0)799 0088714
E-mail: ukpaediatricteam@abbvie.com 
Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating